6-chloro-2-(1-piperazinyl)pyrazine has been researched along with citalopram in 1 studies
| Studies (6-chloro-2-(1-piperazinyl)pyrazine) | Trials (6-chloro-2-(1-piperazinyl)pyrazine) | Recent Studies (post-2010) (6-chloro-2-(1-piperazinyl)pyrazine) | Studies (citalopram) | Trials (citalopram) | Recent Studies (post-2010) (citalopram) |
|---|---|---|---|---|---|
| 157 | 8 | 24 | 5,348 | 1,424 | 2,350 |
| Protein | Taxonomy | 6-chloro-2-(1-piperazinyl)pyrazine (IC50) | citalopram (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.297 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.196 | |
| Aromatase | Rattus norvegicus (Norway rat) | 0.0018 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.196 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 3.289 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.297 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0227 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.0027 | |
| Histamine H1 receptor | Homo sapiens (human) | 3.194 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 1.839 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.1869 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.398 | |
| Transporter | Rattus norvegicus (Norway rat) | 8.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikane, T | 1 |
1 other study(ies) available for 6-chloro-2-(1-piperazinyl)pyrazine and citalopram
| Article | Year |
|---|---|
[Effects of serotonergic drugs on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum].
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Dyskinesia Agents; Antipsychotic Agents; Citalopram; Corpus Striatum; Dopamine Antagonists; Haloperidol; Male; Pyrazines; Rats; Rats, Wistar; Receptors, Dopamine D2; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Up-Regulation | 1998 |